Head & Neck/Thyroid Cancers
Article
Cancer Data Trends 2022
News
Two leading oral cancer treatment guidelines differ on recurrence and survival predictions
CAP guidance predicted recurrence and survival, but RCPath guidance did not.
News
Rise in oral cancers among young nonsmokers points to immunodeficiency
A study of 2,073 patients shows nonsmokers have higher mortality rates compared with smokers.
News
Few new cancer drugs replace current standards of care
Newer drugs could benefit patients but could increase the cost of care.
Opinion
Ways to lessen toxic effects of chemo in older adults
Three recent high-quality randomized trials evaluated the use of geriatric assessment in older adults with cancer.
News
Radioactive iodine shows no benefit in low-risk thyroid cancer
The study’s take-home message for clinicians should be to “stop systematic radioiodine ablation administration in low-risk thyroid cancer patients...
Conference Coverage
Can liquid biopsy predict oropharyngeal cancer recurrence?
News
Radiofrequency ablation an option for thyroid microcarcinoma
RFA might be a good option for high risk surgical patients and patients who forgo active surveillance.
News
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinoma
Chemotherapy-induced toxic effects, such as renal dysfunction, have always been a major concern in nasopharyngeal carcinoma.
News
Brain tumors exact higher mortality toll in men than women
“We cannot discount the role of sex differences in diagnosis, treatment, or behavioral risk factors that may underlie the better survival for...
